Vaxon Biotech - Company Review
Vaxon Biotech - Company ReviewSummary
Vaxon Biotech (Vaxon) is a therapeutic vaccine developer for the treatment of cancer. The company carries out the development of vaccines by utilizing its optimized cryptic peptide vaccine technology. Its technology targets cryptic peptides present on tumor cell surface to improve immune response and make vaccines more effective. Vaxon’s Vx-001 is an advanced vaccine used in the treatment of non small cell lung cancer, breast cancer and hepatocellular carcinoma. The company has a pipeline of tumor vaccines that cover major HLA-I to treat cancer patients. Its products are used in the treatment of various other cancers such as gastric, liver, prostate, renal and colorectal cancers. Vaxon is headquartered in Paris, France.
This comprehensive company report of Vaxon Biotech provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.